logo

For the Inventor, By the Inventor

Mainz, Germany

Alexander Muik

This inventor holds 18 USPTO granted patents and 30 published patent applications, primarily in Immunotherapy Development. Top assignees: Biontech Se, Genmab A+s, Instadeep Ltd. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Muik. Retrieved from https://idiyas.com/inventor/alexander-muik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 94.4

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Mainz, DE (2021 - 2024)
  • Seeheim-Jugenheim, DE (2023 - 2024)

Company Filing History:

goldMedal16 out of 77 
 
Biontech Se
 patents
silverMedal5 out of 107 
 
Genmab A+s
 patents
bronzeMedal2 out of 6 
 
Instadeep Ltd
 patents
4. 1 out of 8 
 
Biontech Cell & Gene Therapies Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...
Areas of Expertise:
Graphical User Interface
IL2 Agonists
Binding Agents
PD-L1
CD137
Interleukin-2
Monoclonal Antibodies
Coronavirus Vaccine
Immune Effector Cells
Cancer Treatment
Immunotherapy
Vaccine Development
18 patents (USPTO):Explore Patents
1. 12780930 - ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF (2026-11-03),
2. D1154704 - Graphical user interface for a display screen or portion thereof (2026-10-20),
3. D1154703 - Graphical user interface for a display screen or portion thereof (2026-10-20),
4. 12643930 - IL2 Agonists (2026-06-02),
5. 12637515 - BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF (2026-05-26),
6. 12595292 - Interleukin-2 receptor (IL2R) and interleukin-2 (IL2) variants for specific activation of immune effector cells (2026-04-07),
7. 12570751 - BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF (2026-03-10),
8. 12522640 - IL2 Agonists (2026-01-13),
9. 12398214 - Binding agents binding to EpCAM and CD137 (2025-08-26),
10. 12208136 - Coronavirus vaccine (2025-01-28),
11. 12186387 - Coronavirus vaccine (2025-01-07),
12. 12133899 - Coronavirus vaccine (2024-11-05),
13. 11932693 - Monoclonal antibodies directed against programmed death-1 protein and their use in medicine (2024-03-19),
14. 11925694 - Coronavirus vaccine (2024-03-12),
15. 11878055 - Coronavirus vaccine (2024-01-23),

Title: Alexander Muik - Innovative Inventor from Mainz

Introduction: Alexander Muik is a renowned inventor hailing from Mainz, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Alexander Muik holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Alexander Muik has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Alexander Muik has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Alexander Muik's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…